nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

24.09.2018 | Head & Neck

Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer

verfasst von: Tristan Tham, Caitlin Olson, Michael Wotman, Sireesha Teegala, Julian Khaymovich, Josephine Coury, Peter Costantino

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hemoglobin is a known prognostic marker in many cancers, including head and neck cancer (HNC). There is some evidence that the red cell distribution width, which is an index of variation in size of red blood cells (RBCs), might be associated with prognosis as well. Recently, a novel prognostic biomarker has been reported—the ratio of the hemoglobin-to-red cell distribution width (Hb/RDW). Our objective was to evaluate the prognostic utility of the pretreatment Hb/RDW in HNC, controlled with known prognostic indices.

Methods

Retrospective cohort study in a tertiary academic hospital setting. Patients diagnosed with HNC treated with curative-intent surgery were eligible. Metastatic disease was excluded. The variables collected were age, sex, BMI, alcohol/tobacco exposure, performance scores, ACE-27, tumor characteristics, adjuvant treatment, and lab values. The primary endpoints were event-free survival (EFS) and overall survival (OS). OS was defined as time from start of treatment to death from any cause, and EFS was defined as time from start of treatment to any progression, recurrence, or death from any cause. Univariate and multivariate survival analysis was performed on the primary endpoints.

Results

A total of 205 patients were enrolled from 2010 to 2016. In multivariate analysis, the factors independently associated with EFS were BMI (p = 0.0364), advanced T stage (p = 0.001), and low Hb/RDW ratio (p = 0.017). The factors independently associated with OS were ECOG score (p = 0.042), advanced T stage (p < 0.0001), positive nodes (p = 0.0195), and Hemoglobin (0.0134).

Conclusion

A low Hb/RDW ratio was associated with poorer EFS (HR = 2.02, 95% CI 1.13–3.61, p = 0.017), but was not associated with OS. This is the first study reporting the prognostic utility of Hb:RDW in head and neck cancer.

Nur mit Berechtigung zugänglich

Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRef

Valero C, Pardo L, López M et al (2017) Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer. Head Neck 39(2):219–226CrossRef

Tham T, Bardash Y, Teegala S, Herman SW, Costantino PD (2018) The red cell distribution width as a prognostic indicator in upper aerodigestive tract (UADT) cancer: a systematic review and meta-analysis. Am J Otolaryngol. https://doi.org/10.1016/j.amjoto.2018.04.013 CrossRefPubMed

Tham T, Olson C, Khaymovich J, Herman SW, Costantino PD (2018) The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-018-4972-x CrossRefPubMed

Tham T, Bardash Y, Herman SW, Costantino PD (2018) Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis. Head Neck. https://doi.org/10.1002/hed.25324 CrossRefPubMed

Tonelli M, Sacks F, Arnold M et al (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117(2):163–168CrossRef

Warwick R, Mediratta N, Shackcloth M et al (2013) Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg 45(1):108–113CrossRef

Seretis C, Seretis F, Lagoudianakis E, Gemenetzis G, Salemis NS (2013) Is red cell distribution width a novel biomarker of breast cancer activity? Data from a pilot study. J Clin Med Res 5(2):121PubMedPubMedCentral

Wang F-M, Xu G, Zhang Y, Ma L-L (2014) Red cell distribution width is associated with presence, stage, and grade in patients with renal cell carcinoma. Dis Markers. https://doi.org/10.1155/2014/860419 CrossRefPubMedPubMedCentral

10.

Hu L, Li M, Ding Y et al (2017) Prognostic value of RDW in cancers: a systematic review and meta-analysis. Oncotarget 8(9):16027PubMed

11.

Dubray B, Mosseri V, Brunin F et al (1996) Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 201(2):553–558CrossRef

12.

Guo S-S, Tang L-Q, Chen Q-Y et al (2015) Is hemoglobin level in patients with nasopharyngeal carcinoma still a significant prognostic factor in the era of intensity-modulated radiotherapy technology? PLoS One 10(8):e0136033CrossRef

13.

Cordella C, Luebbers H-T, Rivelli V, Grätz KW, Kruse AL (2011) An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck Oncol 3(1):35CrossRef

14.

Ye X, Liu J, Chen Y, Wang N, Lu R (2015) The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients. Int J Clin Exp Med 8(3):4228PubMedPubMedCentral

15.

Shin N-R, Lee Y-Y, Kim S-H et al (2014) Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer. Obstet Gynecol Sci 57(1):28–36CrossRef

16.

Zhang F, Han H, Wang C et al (2013) A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy. World J Surg Oncol 11(1):249CrossRef

17.

Sun P, Zhang F, Chen C et al (2016) The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China. Oncotarget 7(27):42650PubMedPubMedCentral

18.

Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291(20):2441–2447CrossRef

19.

Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRef

20.

Michiels S, Le Maître A, Buyse M et al (2009) Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 10(4):341–350CrossRef

21.

Machin D, Campbell MJ, Tan S-B, Tan S-H (2011) Sample size tables for clinical studies. Wiley, Hoboken

22.

Budczies J, Klauschen F, Sinn BV et al (2012) Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One 7(12):e51862CrossRef

23.

van Leeuwen PA, Kuik DJ, Klop WMC et al (1999) The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86(3):519–527CrossRef

24.

Proctor M, Morrison D, Talwar D et al (2011) An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 104(4):726CrossRef

25.

Sun W, Zhang L, Luo M et al (2016) Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Head Neck 38(Suppl 1):E1332–E1340CrossRef

26.

Khandavilli SD, Ceallaigh P, Lloyd CJ, Whitaker R (2009) Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 45(10):912–914CrossRef

27.

Compton C (2018) Precision medicine core: progress in prognostication—populations to patients. Ann Surg Oncol 25(2):349–350CrossRef

Titel: Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer
verfasst von: Tristan Tham
Caitlin Olson
Michael Wotman
Sireesha Teegala
Julian Khaymovich
Josephine Coury
Peter Costantino
Publikationsdatum: 24.09.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 11/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-018-5144-8

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer